CHINA PHARMA HOLDINGS, INC. Operating Loss Carryforwards
CHINA PHARMA HOLDINGS, INC. (CPHI) had Operating Loss Carryforwards of $4.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-08-14
- 2026-06-30: Operating Loss Carryforwards $4.20M.
- 2026-03-31: Operating Loss Carryforwards $4.10M.
- 2025-12-31: Operating Loss Carryforwards $6.80M.
- 2025-09-30: Operating Loss Carryforwards $6.80M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-06-30 | $4.20M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.10M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $6.80M 10-K · filed 2026-04-01 | |
| 2025-09-30 | $6.80M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.70M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.70M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.60M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $22.60M 10-Q · filed 2024-08-14 | |
| 2023-09-30 | $20.80M 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $21.10M 10-K · filed 2024-04-01 | $1.85M 10-K · filed 2023-03-30 |
| 2021-12-31 | $1.60M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.41M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $1.30M 10-K · filed 2021-03-26 | |
| 2018-12-31 | $1.19M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $6.10M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.40M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $6.70M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.08M 10-K · filed 2019-03-28 | |
| 2016-12-31 | $1.52M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $1.36M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $1.18M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |